# The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers

> **NCT01108120** · PHASE2 · COMPLETED · sponsor: **Xiang Guang-da** · enrollment: 200 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** continuous intra-femoral thrombolysis group
- **DRUG:** Conventional therapy group

## Key facts

- **NCT ID:** NCT01108120
- **Lead sponsor:** Xiang Guang-da
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01108120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01108120, "The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT01108120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*